ID: ALA4482948

Max Phase: Preclinical

Molecular Formula: C34H56N6O11

Molecular Weight: 724.85

Molecule Type: Unknown

Representations

Canonical SMILES:  CCCCCCCCCCCCNC(=O)C1=CCN(C)[C@@H]([C@H](O[C@@H]2O[C@H](CN)[C@@H](O)[C@H]2O)[C@H]2O[C@@H](n3ccc(=O)[nH]c3=O)[C@H](O)[C@@H]2O)C(=O)N1C

Standard InChI:  InChI=1S/C34H56N6O11/c1-4-5-6-7-8-9-10-11-12-13-16-36-30(46)20-14-17-38(2)23(31(47)39(20)3)28(51-33-27(45)24(42)21(19-35)49-33)29-25(43)26(44)32(50-29)40-18-15-22(41)37-34(40)48/h14-15,18,21,23-29,32-33,42-45H,4-13,16-17,19,35H2,1-3H3,(H,36,46)(H,37,41,48)/t21-,23+,24-,25+,26-,27-,28+,29+,32-,33+/m1/s1

Standard InChI Key:  USBCRGSIUDLQJF-AFHNBZIUSA-N

Molecule Features

Natural Product: No

Oral: No

Chemical Probe: No

Parenteral: No

Molecule Type: Unknown

Topical: No

First In Class: No

Black Box: No

Chirality: No

Availability: No

Prodrug: No

Properties

Molecular Weight: 724.85

Molecular Weight (Monoisotopic): 724.4007

AlogP: -1.36

#Rotatable Bonds: 18

Polar Surface Area: 242.14

Molecular Species: BASE

HBA: 14

HBD: 7

#RO5 Violations: 3

HBA (Lipinski): 17

HBD (Lipinski): 8

#RO5 Violations (Lipinski): 3

CX Acidic pKa: 9.70

CX Basic pKa: 8.75

CX LogP: -0.62

CX LogD: -1.79

Aromatic Rings: 1

Heavy Atoms: 51

QED Weighted: 0.09

Np Likeness Score: 0.74

References

1. Patel B, Ryan P, Makwana V, Zunk M, Rudrawar S, Grant G..  (2019)  Caprazamycins: Promising lead structures acting on a novel antibacterial target MraY.,  171  [PMID:30933853] [10.1016/j.ejmech.2019.01.071]

2. Arbour CA,Imperiali B.  (2020)  Uridine natural products: Challenging targets and inspiration for novel small molecule inhibitors.,  28  (18): [PMID:32828427] [10.1016/j.bmc.2020.115661]

Source

Source(1):

• Scientific Literature